Open-access Is ejection fraction the best parameter for the assessment of ventricular function?

LETTER TO THE EDITOR

Is ejection fraction the best parameter for the assessment of ventricular function?

Eduardo Maffini da Rosa; Marina Mantesso; Marcio Fernando Spagnól

Liga Acadêmica de Estudos e Ações em Cardiologia, Universidade de Caxias do Sul - UCS, Caxias do Sul, RS - Brazil

Mailing address Mailing address: Marcio Fernando Spagnol Rua Ernesto Alves, 2131/104 - Centro 95020-360 - Caxias do Sul, RS - Brazil E-mail: marciospagnol@gmail.com marciospagnol@hotmail.com

Key words: Stroke volume/drug effects; heart failure; trimetazidina.

Our study group on Heart Failure has paid close attention to the potential benefits of Trimetazidine. However, it should be pointed out that Ventricular Function (VF) may be assessed by several methods, including Ejection Fraction (EF). There are situations in which EF may not be consistent with VF because of its dependence on valvular function, pre-load, post-load, HR, contractile function and use of drugs1. However, VF may be measured by other parameters such as dP/dt2,3, cardiac output, ejection volume and TAU4.

As regards the article "The Effects of Trimetazidine on Heart Rate Variability (HRV) in Patients with Heart Failure"5, recently published in ABC, we find that the major benefit of the drug found in that study, namely the improvement of left ventricular ejection fraction, was strongly influenced by variables such as HR, blood volume, and peripheral resistance, which were not controlled. Therefore, we understand that the improvement of ventricular function elicited by Trimetazidine has not been proven with the variation in ejection fraction observed in that study.

Manuscript received September 19, 2009; revised manuscript received Septemer 19, 2009; accepted September 25, 2009.

Author's Reply

Dear editor,

We thank the authors for their comments on our article "The Effects of Trimetazidine on Heart Rate Variability in Patients with Heart Failure"1. We agree with Rosa et al2 that the measurement of left ventricular function by ejection fraction (EF) may be biased by several factors. Furthermore, heart failure is a continually progressive process and there is no means of guaranteeing the association of subjective changes in echocardiography and clinical condition with drugs or the natural course of heart failure. However, EF is the most commonly used noninvasive way of assessment of ventricular function. In a subsequent study, we analyzed the effects of trimetazidine on ventricular functions with tissue Doppler, which is a relatively load-independent method. We found that trimetazidine added to optimal heart failure treatment improved functional status and left and right ventricular functions based on tissue Doppler velocities in patients with heart failure3. Nevertheless, large-scale multicenter placebo-controlled trials and studies using more reliable methods as stated by Rosa et al2 are necessary to confirm our findings.

Yilmaz Gunes, Yuzuncu Yil University, Faculty of Medicine, Cardiology Department, Van, Turkey.

References

Referências (resposta)

References

  • 1. Wang J, Nagueh SF. Echocardiographic assessment of left ventricular filling pressures. Heart Fail Clin. 2008; 4 (1): 57-70.
  • 2. Yilmaz H, Minareci K, Kabukcu M, Sancaktar O. Diastolic blood pressure-estimated left ventricular dp/dt. Echocardiography. 2002; 19 (2): 89-93.
  • 3. Kolias TJ, Aaronson KD, Armstrong WF. Doppler-derived dP/dt and -dP/dt predict survival in congestive heart failure. J Am Coll Cardiol. 2000; 36 (5): 1594-9.
  • 4. Scalia GM, Greenberg NL, McCarthy PM, Thomas JD, Vandervoort PM. Noninvasive assessment of the ventricular relaxation time constant (tau) in humans by Doppler echocardiography. Circulation. 1997; 95 (1): 151-5.
  • 5. Gunes Y, Guntekin U, Tuncer M, Sahin M. Os efeitos da trimetazidina na variabilidade da frequência cardíaca (VFC) em pacientes com insuficiência cardíaca. Arq Bras Cardiol. 2009; 93 (2): 154-8.
  • 1. Gunes Y, Guntekin U, Tuncer M, Sahin M. The Effects of Trimetazidine on heart rate variability in patients with heart failure. Arq Bras Cardiol 2009; 93(2): 145-8.
  • 2. Rosa EM, Mantesso M, Spagnol MF. Fração de ejeção é o melhor parâmetro para avaliarmos a função ventricular?Arq Bras Cardiol.2010 [In Press]
  • 3. Gunes Y, Guntekin U, Tuncer M, Sahin M. Improved Left and right ventricular functions with trimetazidine in patients with heart failure: a tissue Doppler study. Heart Vessels 2009;24: 277-82.
  • Mailing address:
    Marcio Fernando Spagnol
    Rua Ernesto Alves, 2131/104 - Centro
    95020-360 - Caxias do Sul, RS - Brazil
    E-mail:
  • Publication Dates

    • Publication in this collection
      26 Jan 2011
    • Date of issue
      Oct 2010
    location_on
    Sociedade Brasileira de Cardiologia - SBC Avenida Marechal Câmara, 160, sala: 330, Centro, CEP: 20020-907, (21) 3478-2700 - Rio de Janeiro - RJ - Brazil, Fax: +55 21 3478-2770 - São Paulo - SP - Brazil
    E-mail: revista@cardiol.br
    rss_feed Acompanhe os números deste periódico no seu leitor de RSS
    Acessibilidade / Reportar erro